Clearmind Medicine, Inc. 是一家迷幻藥物製藥生物科技公司。公司總部位於不列顛哥倫比亞省溫哥華。該公司在2021年8月10日上市。公司專注於開發新型迷幻藥衍生成療法,以解決普遍存在且未被充分治療的健康問題,包括酒精使用障礙。公司研究和開發基於迷幻藥的化合物,並嘗試將其作為受監管的藥品、食品或補充劑進行商業化。該公司的知識產權組合包括15個專利家族,其中包含27項已授權專利和24項待審申請。該組合涵蓋多個司法管轄區,包括美國、歐洲、印度和中國。
CMND stock price ended at $1.12 on 星期五, after rising 2.75%
On the latest trading day Feb 13, 2026, the stock price of CMND rose by 2.75%, climbing from $1.09 to $1.12. Throughout the session, the stock experienced a volatility of 8.26%, with prices fluctuating between a daily low of $1.09 and a high of $1.18. Alongside this price increase, trading volume also rose by 10.6K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 31.6K shares were traded, amounting to a market value of approximately $67.1M.